{"id":"W2054340543","doi":"10.1016/s1470-2045(13)70473-x","title":"Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Docetaxel; Cetuximab; Medicine; Oncology; Internal medicine; Open label; Lung cancer; Chemotherapy; Clinical trial; Cancer; Colorectal cancer; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001721261,0.002051384,0.003541879,0.0003954675,0.000450065,0.001302574,0.0009969344,0.001938016,0.006157878],"category_scores_gemma":[0.001640806,0.0008185702,0.002665468,0.0004839067,0.00146419,0.001522365,0.0004678542,0.004383133,0.001199719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001127093,"about_ca_system_score_gemma":0.001025549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002147336,"about_ca_topic_score_gemma":0.004771261,"domain_scores_codex":[0.999281,0.0003440598,0.00004038518,0.0001528314,0.00004887022,0.0001329588],"domain_scores_gemma":[0.9992802,0.0002364361,0.0001292098,0.00005985587,0.00003661185,0.0002577812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9805462,0.002945373,0.000357129,0.0006646035,0.001173676,0.0000431675,0.00006577401,0.0005054777,0.001288945,0.000131616,0.0007081736,0.01156988],"study_design_scores_gemma":[0.9572927,0.04005419,0.001012253,0.0000349369,0.000505078,0.00002849662,0.00002465775,0.0002711895,0.0001773697,0.0001338898,0.0004506891,0.00001443196],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852137,0.006587468,0.0006033611,0.0007993578,0.0008282487,0.002545603,0.001017304,0.0001008685,0.002304013],"genre_scores_gemma":[0.9867932,0.003925177,0.0009017856,0.0008422288,0.0002967956,0.001641055,0.001002194,0.00002658213,0.004570905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006157878,"threshold_uncertainty_score":0.02060014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07556084289108853,"score_gpt":0.4426476036905805,"score_spread":0.367086760799492,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}